• Member Statistics

    • 730,928 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • Our ME-P Channels

  • ME-P Archives Silo [2006 – 2018]

  • Dr. David Marcinko [Publisher-in-Chief]

    As a Distinguished University Professor and Endowed Department Chairman, Dr. David Edward Marcinko MBBS DPM MBA MEd BSc CMP® was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; Oglethorpe University and Atlanta Hospital & Medical Center in GA; and Aachen City University Hospital, Koln-Germany. He is one of the most innovative global thought leaders in health care entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing nonessential expenditures and improving operational efficiencies.

    Professor Marcinko was a board certified physician, surgical fellow, hospital medical staff Vice President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010, by PM magazine. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics and trade publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Dr. Marcinko is also an early-stage investor with a focus on finance, economics and business IT. He was on the initial team for Physicians-Nexus®, 1st. Global Financial Advisors and Physician Services Group Inc; and as a mentor for Deloitte-Touche, Accenture and other start-ups in Silicon Valley, CA.

    As a licensed life and health insurance agent, RIA – SEC registered representative, Dr. Marcinko was Founding Dean of the fiduciary niche focused CERTIFIED MEDICAL PLANNER® online chartered designation education program; as well as Chief Editor of the HEALTH DICTIONARY SERIES® Wiki Project.

    Dr. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”. Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.



  • Hope Hetico RN MS [Managing Editor]

    Prof. Hetico





    USNews.com, Reuters.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details


    New "Self-Directed" Study Option SinceJanuary 1st, 2018
  • PodiatryPrep.org

    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • Most Recent ME-Ps

  • ME-P Free Adverting Sales Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

  • iMBA White Papers

    Customized Industry Topics [$1,500 unlimited corporate license]January 1st, 2018
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • Ann Miller RN MHA [Executive-Director]

    iMBA VIRTUAL OFFICES [1.770.448.0769] Atlanta, GA.
    Location doesn't matter. We welcome new long-distance clients and colleagues.

  • ME-P Publishing


    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. ******************************************************************** THE ME-P DISCLAIMER: Posts, comments and all opinions do not necessarily represent iMBA, Inc. Copyright © 2006 to-date.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov
  • Advertisements

The Central Banks are at it Again!

Join Our Mailing List
Central banks were at it again – and markets loved it!
By Arthur Chalekian GEPC [Elite Financial Partners]
Several weeks ago, European Central Bank (ECB) President Mario Draghi surprised markets when he indicated the ECB’s governing council was considering cutting interest rates and engaging in another round of quantitative easing.
The Economist explained European monetary policy was heavily tilted toward growth before the announcement:
“The ECB is already delivering a hefty stimulus to the Euro area, following decisions taken between June 2014 and early 2015. It has introduced a negative interest rate, of minus 0.2%, which is charged on deposits left by banks with the ECB. It has also been providing ultra-cheap, long-term funding to banks provided that they improve their lending record to the private sector. And, most important of all, in January it announced a full-blooded program of quantitative easing (QE) – creating money to buy financial assets – which got under way in March with purchases of €60 billion ($68 billion) of mainly public debt each month until at least September 2016.”
Despite these hefty measures, recovery in the Euro area has been anemic, and deflation remains a significant issue. According to Draghi, Euro area QE is expected to continue until there is “a sustained adjustment in the path of inflation.” Europe is shooting for 2 percent inflation, just like the United States.
The People’s Bank of China (PBOC) eased monetary policy last week, too. On Monday, data showed the Chinese economy grew by 6.9 percent during the third quarter, year-over-year. Projections for future growth remain muted, according to BloombergBusiness. On Friday, the PBOC indicated it was cutting interest rates for the sixth time in 12 months.
U.S. markets thrilled to the news. The Dow Jones Industrial Average, Standard & Poor’s 500 Index, and NASDAQ were all up more than 2 percent for the week. Many global markets delivered positive returns for the week, as well.
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com




  Risk Management, Liability Insurance, and Asset Protection Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™ Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™



2 Responses

  1. The central banks have done their job …. What now?

    In several major economies, monetary policy is reaching its limits. It seems that every day we see headlines asking: Have central banks run out of ammunition?

    The question dominates the financial markets’ discourse. Its ubiquity reflects the central banks’ unprecedented role in both stabilizing economic growth and supporting asset prices since the end of the global financial crisis. But the question also reflects disappointment. Global growth remains frustratingly fragile. Inflation has stubbornly fallen short of central bank targets.
    This disappointment has led to a negative feedback loop between central banks and the markets. If central banks fail to deliver ever more aggressive stimulus, or even to begin to normalize policy, the markets react like a spoiled child in the candy aisle. Unfortunately, what risks being lost in this monetary-policy debate is the need for a stern reminder that too much candy can make us sick. Monetary stimulus has already done just about all that it should do.

    One analysis suggests that this feedback loop is creating unrealistic expectations for investors and having an unhealthy influence on monetary policy. But if monetary stimulus has already accomplished what it can, what comes next? The answer differs by region. In all cases, however, the answer suggests that it’s time to thank the central bankers for a job well done.
    In the United States, the case for at least two more increases in the federal funds rate in the coming months remains strong. The Federal Reserve may—or may not—be able to preempt any outsized market reaction by making clear that a federal funds rate of 1% is both consistent with all available economic data and a likely outcome. In any case, it’s unwise to give undue weight to short-term volatility.

    The U.S. economy, now in its seventh year of expansion, remains resilient. The job market has tightened to within a whisker of the Fed’s full-employment estimate, despite recent weakness (which we do not view as indicative of a trend). The once-battered housing market is recovering, and inflation and wage trends are inching upward. If investors awoke to this economy after a decade-long slumber, they would surely expect a short-term bank CD or money market fund to yield more than 1%, just as the Fed’s own models indicate.

    One risk of a rate hike is that the dollar will strengthen, impeding continued economic expansion. But minutes from the Fed’s April meeting hint at a sensible plan to address this risk: Pair the rate hikes with a long pause at 1% and a further reduction in the Fed’s long-term “dots”—forecasts of the future federal funds rate—toward 2.5% or lower. The lower rate is more consistent with the long-term growth potential of a developed economy with a slowly growing labor force. It’s also a signal to global markets that there’s a relatively low ceiling on the dollar’s fair value.

    In Europe and Japan, central bankers need to abandon tools that are proving ineffective and perhaps counterproductive, namely negative interest rates and increasingly aggressive quantitative easing. If cuts of several percentage points when interest rates were positive failed to boost credit growth, pushing rates a few basis points more below 0% is unlikely to do the trick. And central banks already purchase 90% of the gross government bond issuance. What’s to be gained from a move toward 100%?

    Japanese corporations and households have been sitting on abundant cash reserves for decades. They have access to whatever capital they might need. After years of near-zero rates, Japanese firms and households still see few reasons to invest and spend. Additional monetary stimulus is unlikely to make much difference. On the contrary, such actions risk damaging central bank credibility as false hopes are dashed and inflation expectations fail to rise materially.

    The European Central Bank and Bank of Japan have earned the right to turn to their policymaking peers and say “it’s your turn” to press forward with structural reforms that can boost long-term productivity growth. Indeed, it’s time to experiment not with helicopter drops but with reforms that can help these economies capitalize on the technological breakthroughs of the past decade. Printing money was the right response to the financial crisis, but it’s not a prescription for long-term economic growth. That’s as true in Brussels and Tokyo as it is in Buenos Aires and Harare.

    The world’s central banks have been the proverbial Atlas in helping to support the global recovery the last seven years. But monetary policy is reaching its limits. The keys to continued economic improvement lie elsewhere. The time has come to give Atlas some needed relief.

    Joe Davis


  2. More on CBs

    Globally, monetary policy remains incredibly easy, with some countries going so far as to use negative rates in an attempt to stimulate growth. Despite low interest rates, inflation expectations continue to drift lower.

    In addition, global bond yields have been trending downward due to structural forces such as lower trend growth, demographics, and debt deleveraging. Extraordinary global monetary actions have not been able to offset these deflationary pressures.

    Now, Central banks played an unprecedented role in stabilizing economic growth and supporting asset prices following the global financial crisis. However, the perception is growing that monetary policy in a number of developed economies is reaching its limits.

    Although extraordinary monetary easing should encourage borrowing, ultra-low and negative rates have squeezed bank profitability and constrained loan supply.

    Many believe extreme monetary policies, such as negative rates, will not meaningfully boost either inflation or economic growth. Instead, the experiments have the potential to increase investors’ risk aversion.

    Government and private sector investment have trailed their pre-crisis growth rates, accompanying slower economic growth among consumers and businesses in the largest economies. Central banks have earned the right to press policymakers on structural reforms and programs to boost growth.

    So, we have long believed U.S. short-term interest rates would be challenged to rise above 1% over the next several years. Other central banks are unlikely to raise rates this decade, making a material rise in government bond yields across the yield curve unlikely.

    Your thoughts?

    Dr. David Edward Marcinko MBA


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: